Characteristics of injecting drug users accessing different types of needle and syringe programme or using secondary distribution

Journal of Public Health

Volumn 32, Issue 3, 2010, Pages 328-335

  Craine, N ^a   Hickman, M ^b   Parry, J V ^c   Smith, J ^d   McDonald, T ^c   Lyons, M ^d  

^a YSBYTY GWYNEDD   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d PUBLIC HEALTH WALES   (United Kingdom)

Author keywords

individual behaviour; population based and preventative services; public health

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BLOOD; BLOOD EXAMINATION; FEMALE; HEALTH CARE DELIVERY; HUMAN; INTERVIEW; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ORGANIZATION AND MANAGEMENT; PREVENTIVE HEALTH SERVICE; SUBSTANCE ABUSE; UNITED KINGDOM; UTILIZATION REVIEW;

ADOLESCENT; ADULT; FEMALE; GREAT BRITAIN; HEALTH SERVICES ACCESSIBILITY; HEMATOLOGIC TESTS; HEPATITIS B ANTIBODIES; HEPATITIS C ANTIBODIES; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEEDLE-EXCHANGE PROGRAMS; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 77956016032     PISSN: 17413842     EISSN: 17413850     Source Type: Journal    
DOI: 10.1093/pubmed/fdp131     Document Type: Article

References (26)

1. Stimson G. Syringe exchange programs for injecting drug users. AIDS 1989;3:353-360
2. Parsons J, Hickman M, Turnbull PJ et al. Over a decade of syringe exchange: results from 1997 UK survey. Addiction 2002;97: 845-850
3. Abdulrahim D, Gordon D, Best D et al. The NTAs 2005 Survey of Needle Exchanges in England. National Treatment Agency for Substance Misuse. Department of Health, 2007.
4. Griesbach D, Abdulrahim D, Gordon D et al. Needle Exchange Provision in Scotland: A Report of the National Needle Exchange Survey. Edinburgh: Scottish Executive, 2006.
5. Rhodes T, Watts L, Davies S et al. Risk, shame and the public njector: a qualitative study of drug injecting in South Wales. Soc Sci Med 2007;65(3):572-585
6. Cattan M, Bagnall A, Akhionbare K et al. Injecting Equipment Schemes for Injecting Drug Users Qualitative Evidence Review. Final Revised Report 2008. National Institute for Health and Clinical Excellence. (23 December 2008, date last accessed).
7. Palmateer N, Kimber J, Hickman M et al. Evidence for the Effectiveness of Harm Reduction Interventions in Preventing Hepatitis C Transmission among Injecting Drug Users: A Review of Reviews. Report for the Prevention Working Groups of the ACMD and Hepatitis C Action Plan for Scotland. May 2008. Executive Summary. http:// www.hepcscotland.co.uk/pdfs/p-Evidence-for-the-Effectiveness- of- Harm-Reduction-review-EXECUTIVE%20SUMMARY-2008- 05.pdf (8 February 2010, date last accessed).
8. Wodak A, Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst Use Misuse 2006;41(6-7): 777-813.
9. Strathdee SA, Patrick DM, Currie SL et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 1997;11(8):F59-65.
10. Thein H, Denoe M, van Beek I et al. Injecting behaviour of injecting drug users at needle and syringe programmes and pharmacies in Australia. Int J Drug Policy 2003;14:425-430
11. Miller C, Tyndall M, Spittal P et al. Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges. J Urban Health 2002;79(2): 257-265
12. Riley E, Safaeian M, Strathdee S et al. Comparing new participants of a mobile versus a pharmacy-based needle exchange program. J Acquir Immune Defic Syndr 2000;24:57-61.
13. De P, Cox J, Boivin J et al. Social network-related risk factors for bloodborne virus infections among injection drug users receiving syringes through secondary exchange. J Urban Health 2008;85(1): 77-89.
14. Cao W, Treloar C. Comparison of needle and syringe programme attendees and non-attendees from a high drug-using area in Sydney, New South Wales. Drug Alcohol Rev 2006;25:439-444
15. Huo D, Bailey SL, Hershow RC, Ouellet L. Drug use and HIV risk practices of secondary and primary needle exchange users. AIDS Educ Prev 2005;17(2):170-184
16. Tyndall MW, Bruneau J, Brogly S et al. Satellite needle distribution among injection drug users: policy and practice in two Canadian cities. J Acquir Immune Defic Syndr 2002;31(1):98-105.
17. Bryant J, Treloar C. Risk practices and other characteristics of injecting drug users who obtain injecting equipment from pharmacies and personal networks. Int J Drug Policy 2006;17: 418-424
18. Bluthenthal RN, Ridgeway G, Schell T et al. Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injecting drug users. Addiction 2007;102:638-646
19. Craine N, Hickman M, Parry J et al. Hepatitis C virus incidence amongst drug injectors: effects of opiate substitution treatment and homelessness. J Epidemiol Infect 2009;19:1-11.
20. Judd A, Parry J, Hickman M et al. Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots. Journal of Medical Virology 2003;71:49-55.
21. Hickman M, Hope V, Brady T et al. Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004. J Viral Hepat 2007;14(9):645-652
22. Lorvick J, Bluthenthal RN, Scott A et al. Secondary syringe exchange among users of 23 California syringe exchange programs. Subst Use Misuse 2006;41(6-7):865-882
23. Valente TW, Foreman RK, Junge B et al. Needle-exchange participation, effectiveness, and policy: Syringe relay, gender, and the paradox of public health. J Urban Health 2001;78(2):340-349
24. Bluthenthal RN, Anderson R, Flynn NM et al. Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients. Drug Alcohol Depend 2007;89(2-3):214-222
25. Shaw SY, Shah L, Jolly AM et al. Determinants of injection drug user (IDU) syringe sharing: the relationship between availability of syringes and risk network member characteristics in Winnipeg, Canada. Addiction 2007;102:1626-1635
26. Bryant J, Hopwood M. Secondary exchange of sterile injecting equipment in a high distribution environment: a mixed method analysis in south east Sydney, Australia. Int J Drug Policy 2009;20(4):324-328